CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway. (Q38908550)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

CCR9-CCL25 interaction suppresses apoptosis of lung cancer cells by activating the PI3K/Akt pathway (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Baijun Li

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Zhiwei Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Yonglong Zhong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Jiao Lan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Xiangwei Li

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

publication date

18 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25691296%20AND%20SRC:MED&resulttype=core&format=json

Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Down-regulation of MSH2 expression by Hsp90 inhibition enhances cytotoxicity affected by tamoxifen in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Paracrine Activation of Chemokine Receptor CCR9 Enhances The Invasiveness of Pancreatic Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

CCR9 interactions support ovarian cancer cell survival and resistance to cisplatin-induced apoptosis in a PI3K-dependent and FAK-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Reactivation of AKT signaling following treatment of cancer cells with PI3K inhibitors attenuates their antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Multiple analyses of G-protein coupled receptor (GPCR) expression in the development of gefitinib-resistance in transforming non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Targeting GPCR-mediated p70S6K activity may improve head and neck cancer response to cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

The dichotomy of the Insulin-like growth factor 1 receptor: RTK and GPCR: friend or foe for cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Circulating human rotavirus specific CD4 T cells identified with a class II tetramer express the intestinal homing receptors α4β7 and CCR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Characterization of the CCR3 and CCR9 genes in miiuy croaker and different selection pressures imposed on different domains between mammals and teleosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Antitumor effects of a monoclonal antibody to human CCR9 in leukemia cell xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Blocking of c-FLIP(L)--independent cycloheximide-induced apoptosis or Fas-mediated apoptosis by the CC chemokine receptor 9/TECK interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

The activation of Akt/PKB signaling pathway and cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

PI3K/AKT signaling pathway and cancer: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Role of the Akt/mTOR survival pathway in cisplatin resistance in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0531-0

Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway

21 January 2018

1 reference

12 December 2020

CCR9 as a prognostic marker and therapeutic target in hepatocellular carcinoma

1 reference

12 December 2020

[New prospects for chemokines]

1 reference

12 December 2020

Cancer statistics, 2014

1 reference

12 December 2020

Premature expression of chemokine receptor CCR9 impairs T cell development

1 reference

12 December 2020